vs
Natural Grocers by Vitamin Cottage, Inc.（NGVC）与Prestige Consumer Healthcare Inc.（PBH）财务数据对比。点击上方公司名可切换其他公司
Natural Grocers by Vitamin Cottage, Inc.的季度营收约是Prestige Consumer Healthcare Inc.的1.2倍（$335.6M vs $283.4M），Prestige Consumer Healthcare Inc.净利率更高（16.5% vs 3.4%，领先13.1%），Natural Grocers by Vitamin Cottage, Inc.同比增速更快（1.6% vs -2.4%），Prestige Consumer Healthcare Inc.自由现金流更多（$75.3M vs $11.6M），过去两年Natural Grocers by Vitamin Cottage, Inc.的营收复合增速更高（4.4% vs 1.2%）
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
Prestige Consumer Healthcare Inc.是一家美国企业，主营非处方健康护理产品及家用清洁产品的营销与分销业务。该公司于1996年由Medtech Products、Prestige Brands International及Spic and Span三家公司合并成立，总部位于纽约州塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
NGVC vs PBH — 直观对比
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $335.6M | $283.4M |
| 净利润 | $11.3M | $46.7M |
| 毛利率 | 29.5% | 55.5% |
| 营业利润率 | 4.4% | 29.1% |
| 净利率 | 3.4% | 16.5% |
| 营收同比 | 1.6% | -2.4% |
| 净利润同比 | 14.0% | -23.5% |
| 每股收益（稀释后） | $0.49 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $335.6M | $283.4M | ||
| Q3 25 | $336.1M | $274.1M | ||
| Q2 25 | $328.7M | $249.5M | ||
| Q1 25 | $335.8M | $296.5M | ||
| Q4 24 | $330.2M | $290.3M | ||
| Q3 24 | $322.7M | $283.8M | ||
| Q2 24 | $309.1M | $267.1M | ||
| Q1 24 | $308.1M | $277.0M |
| Q4 25 | $11.3M | $46.7M | ||
| Q3 25 | $11.8M | $42.2M | ||
| Q2 25 | $11.6M | $47.5M | ||
| Q1 25 | $13.1M | $50.1M | ||
| Q4 24 | $9.9M | $61.0M | ||
| Q3 24 | $9.0M | $54.4M | ||
| Q2 24 | $9.2M | $49.1M | ||
| Q1 24 | $8.0M | $49.5M |
| Q4 25 | 29.5% | 55.5% | ||
| Q3 25 | 29.5% | 55.3% | ||
| Q2 25 | 29.9% | 56.2% | ||
| Q1 25 | 30.3% | 57.3% | ||
| Q4 24 | 29.9% | 55.5% | ||
| Q3 24 | 29.6% | 55.5% | ||
| Q2 24 | 29.2% | 54.7% | ||
| Q1 24 | 29.3% | 54.8% |
| Q4 25 | 4.4% | 29.1% | ||
| Q3 25 | 4.6% | 29.1% | ||
| Q2 25 | 4.7% | 28.8% | ||
| Q1 25 | 5.2% | 29.8% | ||
| Q4 24 | 4.0% | 31.7% | ||
| Q3 24 | 3.7% | 29.7% | ||
| Q2 24 | 4.2% | 27.0% | ||
| Q1 24 | 3.7% | 29.7% |
| Q4 25 | 3.4% | 16.5% | ||
| Q3 25 | 3.5% | 15.4% | ||
| Q2 25 | 3.5% | 19.0% | ||
| Q1 25 | 3.9% | 16.9% | ||
| Q4 24 | 3.0% | 21.0% | ||
| Q3 24 | 2.8% | 19.2% | ||
| Q2 24 | 3.0% | 18.4% | ||
| Q1 24 | 2.6% | 17.9% |
| Q4 25 | $0.49 | $0.97 | ||
| Q3 25 | $0.51 | $0.86 | ||
| Q2 25 | $0.50 | $0.95 | ||
| Q1 25 | $0.56 | $1.00 | ||
| Q4 24 | $0.43 | $1.22 | ||
| Q3 24 | $0.38 | $1.09 | ||
| Q2 24 | $0.40 | $0.98 | ||
| Q1 24 | $0.35 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $62.4M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $220.0M | $1.8B |
| 总资产 | $668.6M | $3.5B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
| Q4 25 | $23.2M | $62.4M | ||
| Q3 25 | $17.1M | $119.1M | ||
| Q2 25 | $13.2M | $139.5M | ||
| Q1 25 | $21.2M | $97.9M | ||
| Q4 24 | $6.3M | $50.9M | ||
| Q3 24 | $8.9M | $51.5M | ||
| Q2 24 | $13.9M | $34.3M | ||
| Q1 24 | $11.0M | $46.5M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $993.1M | ||
| Q2 25 | — | $992.7M | ||
| Q1 25 | — | $992.4M | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $220.0M | $1.8B | ||
| Q3 25 | $212.4M | $1.8B | ||
| Q2 25 | $202.5M | $1.9B | ||
| Q1 25 | $193.0M | $1.8B | ||
| Q4 24 | $181.9M | $1.8B | ||
| Q3 24 | $174.3M | $1.7B | ||
| Q2 24 | $167.8M | $1.7B | ||
| Q1 24 | $160.0M | $1.7B |
| Q4 25 | $668.6M | $3.5B | ||
| Q3 25 | $670.5M | $3.4B | ||
| Q2 25 | $659.0M | $3.4B | ||
| Q1 25 | $664.6M | $3.4B | ||
| Q4 24 | $648.9M | $3.3B | ||
| Q3 24 | $655.5M | $3.3B | ||
| Q2 24 | $654.4M | $3.3B | ||
| Q1 24 | $656.6M | $3.3B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.54× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.1M | $78.3M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | $75.3M |
| 自由现金流率自由现金流/营收 | 3.4% | 26.6% |
| 资本支出强度资本支出/营收 | 2.9% | 1.1% |
| 现金转化率经营现金流/净利润 | 1.86× | 1.68× |
| 过去12个月自由现金流最近4个季度 | $42.6M | $267.2M |
8季度趋势，按日历期对齐
| Q4 25 | $21.1M | $78.3M | ||
| Q3 25 | $15.6M | $57.5M | ||
| Q2 25 | $2.9M | $79.0M | ||
| Q1 25 | $34.1M | $61.8M | ||
| Q4 24 | $2.7M | $65.1M | ||
| Q3 24 | $24.5M | $69.8M | ||
| Q2 24 | $12.4M | $54.8M | ||
| Q1 24 | $20.2M | $66.9M |
| Q4 25 | $11.6M | $75.3M | ||
| Q3 25 | $7.5M | $55.4M | ||
| Q2 25 | $-4.2M | $78.2M | ||
| Q1 25 | $27.6M | $58.4M | ||
| Q4 24 | $-6.9M | $63.5M | ||
| Q3 24 | $18.0M | $67.8M | ||
| Q2 24 | $3.6M | $53.6M | ||
| Q1 24 | $9.8M | $63.8M |
| Q4 25 | 3.4% | 26.6% | ||
| Q3 25 | 2.2% | 20.2% | ||
| Q2 25 | -1.3% | 31.3% | ||
| Q1 25 | 8.2% | 19.7% | ||
| Q4 24 | -2.1% | 21.9% | ||
| Q3 24 | 5.6% | 23.9% | ||
| Q2 24 | 1.2% | 20.1% | ||
| Q1 24 | 3.2% | 23.0% |
| Q4 25 | 2.9% | 1.1% | ||
| Q3 25 | 2.4% | 0.8% | ||
| Q2 25 | 2.2% | 0.3% | ||
| Q1 25 | 1.9% | 1.2% | ||
| Q4 24 | 2.9% | 0.5% | ||
| Q3 24 | 2.0% | 0.7% | ||
| Q2 24 | 2.9% | 0.4% | ||
| Q1 24 | 3.4% | 1.1% |
| Q4 25 | 1.86× | 1.68× | ||
| Q3 25 | 1.32× | 1.36× | ||
| Q2 25 | 0.25× | 1.66× | ||
| Q1 25 | 2.60× | 1.23× | ||
| Q4 24 | 0.27× | 1.07× | ||
| Q3 24 | 2.72× | 1.28× | ||
| Q2 24 | 1.35× | 1.12× | ||
| Q1 24 | 2.54× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
